Biden Administration May Declare Monkeypox a Public Health Emergency

TUESDAY, July 26, 2022 (HealthDay News) — As monkeypox continues to spread, with nearly 3,500 cases now reported in the United States, the Biden administration is weighing whether to declare the outbreak a public health emergency.

The administration may also name a White House coordinator to supervise the response, all in an effort to keep the virus from becoming endemic in the United States. On Saturday, the World Health Organization declared monkeypox a global health emergency.

Biden’s decision could come this week, paired with an announcement that about 800,000 additional vaccines will be distributed after a U.S. Food and Drug Administration review, unnamed sources told The Washington Post. Declaring an emergency could provide government agencies with the resources to collect data and fight the spread of monkeypox. Still, it will not address vaccine shortages or treatment barriers that have slowed the U.S. response to the virus.

A declaration is “a tool that could be used to both align with WHO and raise additional awareness, as well as provide significant justification for HHS [Department of Health and Human Services] to use (though limited) tools that would aid in the response,” according to a memo sent to President Joe Biden on Sunday, a copy of which was obtained by The Post.

Some have claimed that the official U.S. response has been too slow. White House officials have been among them, saying the decision is in the hands of HHS Secretary Xavier Becerra. Patients have had delays in getting test results. Doctors have noted bureaucratic barriers in accessing prescriptions. New York Mayor Eric Adams has called for a boost to rapidly declining vaccine doses, The Post reported.

“Our focus is on getting HHS to move as quickly as possible … it’s about strengthening and accelerating the response, not just tacking on a different name,” an official familiar with the response told The Post, saying Biden “is pushing HHS to get vaccine allocations out the door, and pushing FDA to get the vaccine cleared in the next few days, without cutting corners.”

The Washington Post Article